EG24462A - Compounds for treating fundic disaccomodation - Google Patents

Compounds for treating fundic disaccomodation

Info

Publication number
EG24462A
EG24462A EG20010661A EG20010661A EG24462A EG 24462 A EG24462 A EG 24462A EG 20010661 A EG20010661 A EG 20010661A EG 20010661 A EG20010661 A EG 20010661A EG 24462 A EG24462 A EG 24462A
Authority
EG
Egypt
Prior art keywords
disaccomodation
fundic
treating
compounds
treating fundic
Prior art date
Application number
EG20010661A
Other languages
English (en)
Inventor
Kristof Van Emelen
Marcel F De Bruyn
Manuel J Alcazar-Vaca
Jose I Andres-Gil
Francisco J Fernandez-Gadea
Maria E Matesanz-Ballesteros
Jose M Bartolome-Nebreda
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Application granted granted Critical
Publication of EG24462A publication Critical patent/EG24462A/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D495/00Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D411/00Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen and sulfur atoms as the only ring hetero atoms
    • C07D411/02Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen and sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D411/04Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen and sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/14Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D491/00Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Nutrition Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Hydrogenated Pyridines (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
EG20010661A 2000-06-22 2001-06-20 Compounds for treating fundic disaccomodation EG24462A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP00202180 2000-06-22

Publications (1)

Publication Number Publication Date
EG24462A true EG24462A (en) 2009-07-16

Family

ID=8171674

Family Applications (1)

Application Number Title Priority Date Filing Date
EG20010661A EG24462A (en) 2000-06-22 2001-06-20 Compounds for treating fundic disaccomodation

Country Status (33)

Country Link
US (2) US7081453B2 (es)
EP (1) EP1296987B1 (es)
JP (1) JP4911860B2 (es)
KR (1) KR100821107B1 (es)
CN (2) CN100516066C (es)
AR (1) AR032158A1 (es)
AT (1) ATE312104T1 (es)
AU (1) AU783292B2 (es)
BG (1) BG65895B1 (es)
BR (1) BR0111859B1 (es)
CA (1) CA2410233C (es)
CZ (1) CZ305005B6 (es)
DE (1) DE60115647T2 (es)
EA (1) EA005760B1 (es)
EE (1) EE04878B1 (es)
EG (1) EG24462A (es)
ES (1) ES2254467T3 (es)
HR (1) HRP20020988B1 (es)
HU (1) HU227398B1 (es)
IL (2) IL153559A0 (es)
IS (1) IS2618B (es)
JO (1) JO2352B1 (es)
MX (1) MXPA02012844A (es)
MY (1) MY155267A (es)
NO (1) NO328547B1 (es)
NZ (1) NZ522519A (es)
PA (1) PA8519601A1 (es)
PL (1) PL201656B1 (es)
SA (1) SA01220442B1 (es)
SK (1) SK287730B6 (es)
UA (1) UA74576C2 (es)
WO (1) WO2001098306A1 (es)
ZA (1) ZA200210303B (es)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE256125T1 (de) 1999-06-02 2003-12-15 Janssen Pharmaceutica Nv Aminoalkyl substituierte (benzodioxane, benzofurane oder benzopyrane) derivate
JP2003501428A (ja) 1999-06-02 2003-01-14 ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ ピロリジニル、ピペリジニルもしくはホモピペリジニル置換(ベンゾジオキサン、ベンゾフランもしくはベンゾピラン)誘導体
JO2352B1 (en) * 2000-06-22 2006-12-12 جانسين فارماسيوتيكا ان. في Compounds for the treatment of non-adaptation of the bottom of the uterus
JO2654B1 (en) * 2000-09-04 2012-06-17 شركة جانسين فارماسوتيكا ان. في Multiple aryl caroxa amides are useful as lipid - lowering agents
JO2409B1 (en) 2000-11-21 2007-06-17 شركة جانسين فارماسوتيكا ان. في Second-phenyl carboxy amides are useful as lipid-lowering agents
AU2004233863B2 (en) 2003-04-24 2010-06-17 Incyte Holdings Corporation Aza spiro alkane derivatives as inhibitors of metalloproteases
JP4896476B2 (ja) * 2005-09-16 2012-03-14 広栄化学工業株式会社 メチルオキシメチルアミノピリジン誘導体及びその製造方法
US7999107B2 (en) 2007-01-31 2011-08-16 Merck Sharp & Dohme Corp. Substituted pyrano[2,3-B]pyridine derivatives as cannabinoid-1 receptor modulators
CA2685860A1 (en) * 2007-05-10 2008-11-20 Amr Technology, Inc. Aryl- and heteroaryl-substituted tetrahydrobenzo-1,4-diazepines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin
GEP201706656B (en) 2011-11-11 2017-04-25 Pfizer 2-thiopyrimidinones
MA42035A (fr) 2015-05-05 2018-03-14 Pfizer 2-thiopyrimidinones
CN105481839B (zh) * 2015-11-23 2018-05-11 安徽千和新材料科技发展有限公司 一种光活性环氧啉对映体的制备方法
EP3229193A1 (en) 2016-04-07 2017-10-11 The Boeing Company A computer-implemented method and system for sharing information between passengers and air traffic management stakeholders

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3910930A (en) * 1973-01-04 1975-10-07 Janssen Pharmaceutica Nv 1-{55 1-{8 2-(1,4-Benzodioxan-2-yl)-2-hydroxyethyl{9 -4-piperidyl{56 -2-benzimidazolinones
DE2400049A1 (de) * 1974-01-02 1975-07-10 Spumalit Anstalt Transportkasten aus kunststoff, insbesondere fuer flaschen
GR71865B (es) 1978-03-20 1983-07-07 Ciba Geigy
US4329348A (en) * 1979-02-26 1982-05-11 Ciba-Geigy Corporation N-Oxacyclic-alkylpiperidines as psychostimulants
EP0144101B1 (en) * 1983-11-30 1991-02-06 Janssen Pharmaceutica N.V. Bicyclic heterocyclyl containing n-(bicyclic heterocyclyl)-4-piperidinamines
SI9300097B (en) 1992-02-27 2001-12-31 Janssen Pharmaceutica Nv (benzodioxan, benzofuran or benzopyran) alkylamino) alkyl substituted guanidines
ZA931343B (en) 1992-03-06 1993-09-24 Akzo Nv 1,4-dioxino(2,3-b)pyridine derivatives.
US6403103B1 (en) * 1994-08-12 2002-06-11 Bio Merieux Trypanosoma cruzi antigen, gene encoding therefore, and methods of detecting and treating chagas disease
FR2744451B1 (fr) * 1996-02-01 1998-04-24 Pf Medicament Nouvelles imidazolidinones, pyrimidinones, et 1,3-diazepin-2 -ones, leur preparation et leurs applications en therapeutique
US6133277A (en) * 1997-12-05 2000-10-17 Janssen Pharmaceutica N.V. (Benzodioxan, benzofuran or benzopyran) derivatives having fundic relaxation properties
ATE256125T1 (de) 1999-06-02 2003-12-15 Janssen Pharmaceutica Nv Aminoalkyl substituierte (benzodioxane, benzofurane oder benzopyrane) derivate
JP2003501428A (ja) 1999-06-02 2003-01-14 ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ ピロリジニル、ピペリジニルもしくはホモピペリジニル置換(ベンゾジオキサン、ベンゾフランもしくはベンゾピラン)誘導体
TWI225488B (en) * 1999-12-21 2004-12-21 Janssen Pharmaceutica Nv Derivatives of homopiperidinyl substituted benzimidazole analogues
JO2352B1 (en) * 2000-06-22 2006-12-12 جانسين فارماسيوتيكا ان. في Compounds for the treatment of non-adaptation of the bottom of the uterus

Also Published As

Publication number Publication date
HRP20020988B1 (en) 2011-06-30
HU227398B1 (hu) 2011-05-30
ATE312104T1 (de) 2005-12-15
EE200200694A (et) 2004-06-15
JP2004501157A (ja) 2004-01-15
HK1057896A1 (en) 2004-04-23
CA2410233A1 (en) 2001-12-27
IL153559A (en) 2008-03-20
CN100516066C (zh) 2009-07-22
KR20030007566A (ko) 2003-01-23
HRP20020988A2 (en) 2005-02-28
CN1288157C (zh) 2006-12-06
US7081453B2 (en) 2006-07-25
JO2352B1 (en) 2006-12-12
BG65895B1 (bg) 2010-04-30
SA01220442B1 (ar) 2008-05-21
AR032158A1 (es) 2003-10-29
ES2254467T3 (es) 2006-06-16
HUP0301185A3 (en) 2009-03-30
EA005760B1 (ru) 2005-06-30
MXPA02012844A (es) 2003-05-15
WO2001098306A1 (en) 2001-12-27
BR0111859A (pt) 2003-05-13
DE60115647T2 (de) 2006-08-24
ZA200210303B (en) 2004-03-19
CN1437602A (zh) 2003-08-20
CA2410233C (en) 2011-01-25
US7423048B2 (en) 2008-09-09
US20040019051A1 (en) 2004-01-29
NO20026219L (no) 2003-02-17
AU783292B2 (en) 2005-10-13
PL358886A1 (en) 2004-08-23
BG107313A (bg) 2003-06-30
NO20026219D0 (no) 2002-12-23
HUP0301185A2 (hu) 2003-08-28
NZ522519A (en) 2003-09-26
BR0111859B1 (pt) 2015-01-06
CZ305005B6 (cs) 2015-03-25
IL153559A0 (en) 2003-07-06
KR100821107B1 (ko) 2008-04-14
AU8386401A (en) 2002-01-02
CZ2003115A3 (cs) 2003-06-18
PA8519601A1 (es) 2002-08-26
DE60115647D1 (de) 2006-01-12
UA74576C2 (en) 2006-01-16
EP1296987A1 (en) 2003-04-02
IS2618B (is) 2010-04-15
SK492003A3 (en) 2003-07-01
EE04878B1 (et) 2007-08-15
EP1296987B1 (en) 2005-12-07
NO328547B1 (no) 2010-03-15
IS6591A (is) 2002-10-25
US20060142318A1 (en) 2006-06-29
EA200300049A1 (ru) 2003-04-24
PL201656B1 (pl) 2009-04-30
JP4911860B2 (ja) 2012-04-04
CN1781921A (zh) 2006-06-07
SK287730B6 (en) 2011-07-06
MY155267A (en) 2015-09-30

Similar Documents

Publication Publication Date Title
EP1349851A4 (en) COMPOUNDS
GB0027987D0 (en) Compounds
IL153559A0 (en) Compounds for treating impaired fundic relaxation
GB0019950D0 (en) Compounds
AU2405002A (en) Dehalogeno compounds
AU1603401A (en) Pyranoindoles for treating glaucoma
PL351476A1 (en) Thiazoloindolinone compounds
GB0007652D0 (en) Treatment for fabrics
GB0007665D0 (en) Treatment for fabrics
GB0003600D0 (en) Compounds
GB0006800D0 (en) Compounds
GB0014641D0 (en) Compounds
GB0003599D0 (en) Compounds
GB0019578D0 (en) Polysulphamated compounds
GB0003634D0 (en) Compounds
GB0006797D0 (en) Compounds
GB0005370D0 (en) Compounds
GB0003631D0 (en) Compounds
GB0018351D0 (en) Compounds
GB0015853D0 (en) Compounds
GB0003608D0 (en) Compounds
GB0015863D0 (en) Compounds
GB0018306D0 (en) Compounds
GB0004053D0 (en) Compounds
GB0007404D0 (en) Compounds